Avantor (AVTR) Stock Overview
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
AVTR Community Fair Values
Create NarrativeSee what 17 others think this stock is worth. Follow their fair value or set your own to get alerts.
Avantor, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$14.09 |
| 52 Week High | US$26.14 |
| 52 Week Low | US$10.83 |
| Beta | 0.98 |
| 1 Month Change | 5.86% |
| 3 Month Change | 2.47% |
| 1 Year Change | -43.62% |
| 3 Year Change | -29.05% |
| 5 Year Change | -42.77% |
| Change since IPO | -2.83% |
Recent News & Updates
Avantor: Continued Earnings Contraction Phase
Sep 15We Think Avantor (NYSE:AVTR) Is Taking Some Risk With Its Debt
Sep 12
Recent updates
Avantor: Continued Earnings Contraction Phase
Sep 15We Think Avantor (NYSE:AVTR) Is Taking Some Risk With Its Debt
Sep 12Concerns Surrounding Avantor's (NYSE:AVTR) Performance
Aug 12What Is Avantor, Inc.'s (NYSE:AVTR) Share Price Doing?
Jun 26Earnings Working Against Avantor, Inc.'s (NYSE:AVTR) Share Price
May 14Avantor: A Healthier Diagnosis As Expectations Cool
Apr 26At US$17.28, Is Avantor, Inc. (NYSE:AVTR) Worth Looking At Closely?
Mar 11Avantor: Mundane Business, Solid Cash Flow, Potential New Risks
Mar 07Is Avantor (NYSE:AVTR) A Risky Investment?
Feb 18Investors Interested In Avantor, Inc.'s (NYSE:AVTR) Earnings
Jan 28Avantor: Durable FCF Generator Trading For Cheap
Dec 18Why Avantor, Inc. (NYSE:AVTR) Could Be Worth Watching
Dec 04Are Investors Undervaluing Avantor, Inc. (NYSE:AVTR) By 28%?
Nov 16Avantor (NYSE:AVTR) Takes On Some Risk With Its Use Of Debt
Oct 26Avantor: Uninspiring, Even Amidst Some Green Shoots
Oct 24
New Operating Model And Bioprocessing Innovations Promise Robust Growth And Market Leadership
Implementation of a new operating model and ongoing cost transformation initiatives are streamlining execution and improving net margins through cost savings.Avantor: Yet To Evidence Economic Value For Valuation Repricing, Reiterate Hold
Aug 13Avantor: Contracting Growth And Returns On Equity At 37x Earnings - Enemies To The Value Investor
Dec 01Avantor: Customers Destocking, Order Volumes Down, Challenges To Rating (Rating Downgrade)
Sep 08Avantor: Promising Long-Term Buy With Potential For Opportunistic Entry
Jun 28Shareholder Returns
| AVTR | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 19.0% | 14.2% | 1.1% |
| 1Y | -43.6% | -12.1% | 18.9% |
Return vs Industry: AVTR underperformed the US Life Sciences industry which returned -11.7% over the past year.
Return vs Market: AVTR underperformed the US Market which returned 18.4% over the past year.
Price Volatility
| AVTR volatility | |
|---|---|
| AVTR Average Weekly Movement | 7.9% |
| Life Sciences Industry Average Movement | 8.6% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AVTR has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: AVTR's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 13,500 | Emmanuel Ligner | www.avantorsciences.com |
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies.
Avantor, Inc. Fundamentals Summary
| AVTR fundamental statistics | |
|---|---|
| Market cap | US$9.74b |
| Earnings (TTM) | US$687.40m |
| Revenue (TTM) | US$6.67b |
Is AVTR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AVTR income statement (TTM) | |
|---|---|
| Revenue | US$6.67b |
| Cost of Revenue | US$4.45b |
| Gross Profit | US$2.22b |
| Other Expenses | US$1.53b |
| Earnings | US$687.40m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Oct 29, 2025
| Earnings per share (EPS) | 1.01 |
| Gross Margin | 33.25% |
| Net Profit Margin | 10.31% |
| Debt/Equity Ratio | 67.0% |
How did AVTR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/06 12:24 |
| End of Day Share Price | 2025/10/06 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Avantor, Inc. is covered by 34 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Catherine Ramsey Schulte | Baird |
| Ishan Majumdar | Baptista Research |
| Luke Sergott | Barclays |